Back to VA VANGUARD CAPITAL MANAGEMENT LLC
ADPT2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in ADAPTIVE BIOTECHNOLOGIES
Yes. Vanguard Capital Management holds 6,403,587 shares of ADPT (Adaptive Biotechnologies), worth $137.4M, as of its Q2 2026 13F filing. It increased the position by 309,443 shares (+5.1%) from Q1 2026. Vanguard Capital Management has held ADPT in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$137.4M
Current Shares
6.4M
Total Value Change
+$52.8M
Total Shares Change
+309,443
Quarter-by-Quarter History
Other major holders of ADPT: VIKING GLOBAL INVESTORS LP